Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Pacsin 2 is recruited to caveolae and functions in caveolar biogenesis.

Hansen CG, Howard G, Nichols BJ.

J Cell Sci. 2011 Aug 15;124(Pt 16):2777-85. doi: 10.1242/jcs.084319.

2.

Caveolins/caveolae protect adipocytes from fatty acid-mediated lipotoxicity.

Meshulam T, Breen MR, Liu L, Parton RG, Pilch PF.

J Lipid Res. 2011 Aug;52(8):1526-32. doi: 10.1194/jlr.M015628. Epub 2011 Jun 7.

3.

Caveolae and lipid trafficking in adipocytes.

Pilch PF, Meshulam T, Ding S, Liu L.

Clin Lipidol. 2011;6(1):49-58.

4.

Fat caves: caveolae, lipid trafficking and lipid metabolism in adipocytes.

Pilch PF, Liu L.

Trends Endocrinol Metab. 2011 Aug;22(8):318-24. doi: 10.1016/j.tem.2011.04.001. Epub 2011 May 17. Review.

5.

Caveolae at a glance.

Bastiani M, Parton RG.

J Cell Sci. 2010 Nov 15;123(Pt 22):3831-6. doi: 10.1242/jcs.070102. Review. No abstract available.

6.

Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation.

Hayer A, Stoeber M, Ritz D, Engel S, Meyer HH, Helenius A.

J Cell Biol. 2010 Nov 1;191(3):615-29. doi: 10.1083/jcb.201003086.

7.

Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.

Shastry S, Delgado MR, Dirik E, Turkmen M, Agarwal AK, Garg A.

Am J Med Genet A. 2010 Sep;152A(9):2245-53. doi: 10.1002/ajmg.a.33578.

8.

A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4.

Dwianingsih EK, Takeshima Y, Itoh K, Yamauchi Y, Awano H, Malueka RG, Nishida A, Ota M, Yagi M, Matsuo M.

Mol Genet Metab. 2010 Oct-Nov;101(2-3):233-7. doi: 10.1016/j.ymgme.2010.06.016. Epub 2010 Jul 1.

PMID:
20638880
9.

Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.

Rajab A, Straub V, McCann LJ, Seelow D, Varon R, Barresi R, Schulze A, Lucke B, Lützkendorf S, Karbasiyan M, Bachmann S, Spuler S, Schuelke M.

PLoS Genet. 2010 Mar 12;6(3):e1000874. doi: 10.1371/journal.pgen.1000874.

10.

Exploring the caves: cavins, caveolins and caveolae.

Hansen CG, Nichols BJ.

Trends Cell Biol. 2010 Apr;20(4):177-86. doi: 10.1016/j.tcb.2010.01.005. Epub 2010 Feb 12. Review.

PMID:
20153650
11.

Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes.

Hayer A, Stoeber M, Bissig C, Helenius A.

Traffic. 2010 Mar;11(3):361-82. doi: 10.1111/j.1600-0854.2009.01023.x. Epub 2009 Dec 3.

12.

Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.

Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, Park YE, Nonaka I, Hino-Fukuyo N, Haginoya K, Sugano H, Nishino I.

J Clin Invest. 2009 Sep;119(9):2623-33. doi: 10.1172/JCI38660. Epub 2009 Aug 10.

13.

MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes.

Bastiani M, Liu L, Hill MM, Jedrychowski MP, Nixon SJ, Lo HP, Abankwa D, Luetterforst R, Fernandez-Rojo M, Breen MR, Gygi SP, Vinten J, Walser PJ, North KN, Hancock JF, Pilch PF, Parton RG.

J Cell Biol. 2009 Jun 29;185(7):1259-73. doi: 10.1083/jcb.200903053. Epub 2009 Jun 22.

14.

SDPR induces membrane curvature and functions in the formation of caveolae.

Hansen CG, Bright NA, Howard G, Nichols BJ.

Nat Cell Biol. 2009 Jul;11(7):807-14. doi: 10.1038/ncb1887. Epub 2009 Jun 14.

15.

Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes.

González-Muñoz E, López-Iglesias C, Calvo M, Palacín M, Zorzano A, Camps M.

Endocrinology. 2009 Aug;150(8):3493-502. doi: 10.1210/en.2008-1520. Epub 2009 Apr 30.

16.

PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores.

Bickel PE, Tansey JT, Welte MA.

Biochim Biophys Acta. 2009 Jun;1791(6):419-40. doi: 10.1016/j.bbalip.2009.04.002. Epub 2009 Apr 16. Review.

17.

SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function.

McMahon KA, Zajicek H, Li WP, Peyton MJ, Minna JD, Hernandez VJ, Luby-Phelps K, Anderson RG.

EMBO J. 2009 Apr 22;28(8):1001-15. doi: 10.1038/emboj.2009.46. Epub 2009 Mar 5.

18.

Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance.

Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS.

Cell Metab. 2008 Dec;8(6):512-21. doi: 10.1016/j.cmet.2008.10.008.

19.

Filling up adipocytes with lipids. Lessons from caveolin-1 deficiency.

Le Lay S, Blouin CM, Hajduch E, Dugail I.

Biochim Biophys Acta. 2009 Jun;1791(6):514-8. doi: 10.1016/j.bbalip.2008.10.008. Epub 2008 Nov 7. Review.

PMID:
19038362
20.

Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.

Liu L, Brown D, McKee M, Lebrasseur NK, Yang D, Albrecht KH, Ravid K, Pilch PF.

Cell Metab. 2008 Oct;8(4):310-7. doi: 10.1016/j.cmet.2008.07.008.

Supplemental Content

Support Center